About Clarivate JCR-based Journal Impact Factors 2025
The Journal Impact Factor is a journal-level bibliometric indicator published by Clarivate in Journal Citation Reports (JCR). It is often abbreviated as JIF; JIF is not a separate impact factor, but simply the abbreviation for Journal Impact Factor.
The 2025 Journal Impact Factor provides a journal-level indication of citation activity. It should be interpreted within the journal’s subject area and together with other information, rather than used as a stand-alone judgment of research quality.
On this website, you can explore Journal Impact Factor records presented as Clarivate JCR-based data, together with the five-year Impact Factor, JCR quartile (Q1–Q4), JCR category rank, publisher details and journal identifiers. Verify important submission or evaluation decisions in the official Clarivate Journal Citation Reports.
Explore by research area
Browse journals by subject
Start with a broad research area, then narrow the list to a specialty or subsubject. These internal subject groups are provided for discovery and are kept separate from official Journal Citation Reports categories.
Popular specialties
Explore medical journal specialties
Browse focused journal lists within Medicine, including citation metrics, quartiles, publishers and identifiers.
Browse journal metrics
Showing records 3,021–3,030 of 20,480
| Rank | Journal | ISSN / eISSN | JCR Impact Factor | 5-Year Impact Factor | JCR Quartile | JCR Category Rank | Publisher |
|---|---|---|---|---|---|---|---|
| 2,892 |
Service Business SERV BUS |
1862-8516 1862-8508 |
4.100 | 4.400 | Q2 | 126/420 | SPRINGER HEIDELBERG |
| 2,892 |
Social Responsibility Journal SOC RESPONSIB J |
1747-1117 1758-857X |
4.100 | 4.600 | Q2 | 126/420 | EMERALD GROUP PUBLISHING LTD |
| 2,892 |
Sustainable Energy & Fuels SUSTAIN ENERG FUELS |
2398-4902 2398-4902 |
4.100 | 5.100 | Q2 | 186/460 | ROYAL SOC CHEMISTRY |
| 2,892 |
Therapeutic Advances in Musculoskeletal Disease THER ADV MUSCULOSKEL |
1759-720X 1759-7218 |
4.100 | 4.100 | Q1 | 13/58 | SAGE PUBLICATIONS LTD |
| 2,892 |
Therapeutic Advances in Neurological Disorders THER ADV NEUROL DISO |
1756-2856 1756-2864 |
4.100 | 4.600 | Q1 | 50/285 | SAGE PUBLICATIONS LTD |
| 2,892 |
Tissue Engineering and Regenerative Medicine TISSUE ENG REGEN MED |
1738-2696 2212-5469 |
4.100 | 4.200 | Q2 | 45/124 | KOREAN TISSUE ENGINEERING REGENERATIVE MEDICINE SOC |
| 2,892 |
TOXICOLOGICAL SCIENCES TOXICOL SCI |
1096-6080 1096-0929 |
4.100 | 4.000 | Q1 | 23/106 | OXFORD UNIV PRESS |
| 2,892 |
Toxics TOXICS |
N/A 2305-6304 |
4.100 | 4.600 | Q1 | 23/106 | MDPI |
| 2,892 |
Translational Oncology TRANSL ONCOL |
1936-5233 1936-5233 |
4.100 | 4.600 | Q2 | 91/326 | ELSEVIER SCIENCE INC |
| 2,892 |
Tropical Cyclone Research and Review TROP CYCLONE RES REV |
2225-6032 2225-6032 |
4.100 | 4.000 | Q2 | 31/111 | KEAI PUBLISHING LTD |